{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Hepatic+Complication", "query": { "condition": "Hepatic Complication" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 93, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Hepatic+Complication&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T05:38:32.044Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01888302", "title": "Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatic Complication" ], "interventions": [ { "name": "Cisplatin", "type": "DRUG" }, { "name": "Gemcitabine Hydrochloride", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Sirolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2013-09", "completion_date": "2016-06", "has_results": false, "last_update_posted_date": "2016-06-21", "last_synced_at": "2026-05-22T05:38:32.044Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01888302" }, { "nct_id": "NCT02076906", "title": "MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Relapsed Pediatric Solid Tumors", "Refractory Pediatric Solid Tumors", "Rhabdomyosarcoma", "Ewing Sarcoma", "Osteosarcoma", "Neuroblastoma", "Wilms Tumor", "Hepatic Tumor", "Germ Cell Tumor", "Desmoid Tumor" ], "interventions": [ { "name": "Magnetic Resonance High Intensity Focused Ultrasound", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "AeRang Kim", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "30 Years", "sex": "ALL", "summary": "Up to 30 Years" }, "enrollment_count": 7, "start_date": "2014-04", "completion_date": "2024-11-24", "has_results": false, "last_update_posted_date": "2025-01-01", "last_synced_at": "2026-05-22T05:38:32.044Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Cincinnati, Ohio", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02076906" }, { "nct_id": "NCT04440943", "title": "A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non-small Cell Lung Cancer", "Breast Cancer", "Gastric Cancer", "Renal Cell Carcinoma", "Ovarian Cancer", "Primary Peritoneal Carcinoma", "Fallopian Tube Cancer", "Cholangiocarcinoma", "Bladder Urothelial Carcinoma", "MSI-H Colorectal Cancer", "Esophageal Cancer", "Hepatic Cancer", "Head and Neck Cancer", "Other Solid Tumors" ], "interventions": [ { "name": "CDX-527", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celldex Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2020-08-04", "completion_date": "2023-04-06", "has_results": false, "last_update_posted_date": "2023-06-18", "last_synced_at": "2026-05-22T05:38:32.044Z", "location_count": 5, "location_summary": "Atlanta, Georgia • Chicago, Illinois • Omaha, Nebraska + 2 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT04440943" }, { "nct_id": "NCT03963999", "title": "Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Sinusoidal Obstruction Syndrome", "Veno Occlusive Disease, Hepatic", "Bone Marrow Transplant Complications", "Stem Cell Transplant Complications" ], "interventions": [ { "name": "Ultrasound Elastography", "type": "DIAGNOSTIC_TEST" }, { "name": "Contrast Enhanced Ultrasound (CEUS)", "type": "DRUG" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "DRUG" ], "sponsor": "Children's Mercy Hospital Kansas City", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "25 Years", "sex": "ALL", "summary": "1 Month to 25 Years" }, "enrollment_count": 0, "start_date": "2020-04-01", "completion_date": "2025-04-01", "has_results": false, "last_update_posted_date": "2020-01-13", "last_synced_at": "2026-05-22T05:38:32.044Z", "location_count": 1, "location_summary": "Kansas City, Missouri", "locations": [ { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03963999" }, { "nct_id": "NCT06041906", "title": "International Registry of Congenital Portosystemic Shunt (IRCPSS)", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Congenital Portosystemic Shunt", "CPSS (Congenital Portosystemic Shunt)" ], "interventions": [ { "name": "Shunt Closure", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Prof. Valérie Mc Lin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": null, "sex": "ALL", "summary": "1 Day and older" }, "enrollment_count": 500, "start_date": "2018-04-26", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2025-06-18", "last_synced_at": "2026-05-22T05:38:32.044Z", "location_count": 2, "location_summary": "New Haven, Connecticut • Chicago, Illinois", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06041906" }, { "nct_id": "NCT00325611", "title": "Multidisciplinary Inpatient Palliative Care Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cerebrovascular Accident", "Cancer", "Coronary Arteriosclerosis", "Heart Failure, Congestive", "Diabetes Mellitus", "Acquired Immunodeficiency Syndrome", "Failure to Thrive", "Pulmonary Disease, Chronic Obstructive", "Dementia", "Kidney Failure, Chronic", "Pneumonia", "Liver Failure", "Renal Failure", "Respiratory Failure", "Stroke" ], "interventions": [ { "name": "Multidisciplinary palliative care team met with patient", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 550, "start_date": "2002-04", "completion_date": "2004-07", "has_results": false, "last_update_posted_date": "2006-05-15", "last_synced_at": "2026-05-22T05:38:32.044Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00325611" }, { "nct_id": "NCT01431378", "title": "Pilot Study of Model Based Iterative Reconstruction Using 64-Slice", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Posterior Fossa Hemorrhage", "Lung Cancer", "Flank Pain", "Urolithiasis", "Focal Hepatic Necrosis" ], "interventions": [], "intervention_types": [], "sponsor": "GE Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 92, "start_date": "2011-09", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2015-12-11", "last_synced_at": "2026-05-22T05:38:32.044Z", "location_count": 3, "location_summary": "Boston, Massachusetts • Durham, North Carolina • Miwaukee, Wisconsin", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Miwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01431378" }, { "nct_id": "NCT02921828", "title": "A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Multiple Myeloma" ], "interventions": [], "intervention_types": [], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1149, "start_date": "2015-04-30", "completion_date": "2015-12-10", "has_results": false, "last_update_posted_date": "2022-07-05", "last_synced_at": "2026-05-22T05:38:32.044Z", "location_count": 1, "location_summary": "No City Provided, New Jersey", "locations": [ { "city": "No City Provided", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02921828" }, { "nct_id": "NCT06000748", "title": "NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Acute Kidney Injury", "Cirrhosis", "Portal Hypertension", "Hepatorenal Syndrome", "Acute Tubule Necrosis", "Prerenal Failure" ], "interventions": [ { "name": "MAP-Target Algorithm", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2024-02-01", "completion_date": "2024-07-31", "has_results": false, "last_update_posted_date": "2025-05-15", "last_synced_at": "2026-05-22T05:38:32.044Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06000748" }, { "nct_id": "NCT02687763", "title": "Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "RENAL INSUFFICIENCY, CHRONIC", "LIVER FAILURE, ACUTE", "HEART DISEASE" ], "interventions": [ { "name": "ProQuad", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "24 Months", "sex": "ALL", "summary": "6 Months to 24 Months" }, "enrollment_count": 5, "start_date": "2015-12", "completion_date": "2016-11-03", "has_results": false, "last_update_posted_date": "2019-02-12", "last_synced_at": "2026-05-22T05:38:32.044Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02687763" } ] }